Presentation is loading. Please wait.

Presentation is loading. Please wait.

MHRP  The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense.

Similar presentations


Presentation on theme: "MHRP  The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense."— Presentation transcript:

1 MHRP  The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense. CDR Jennifer Malia, DrPH U.S. Public Health Service Corps Military HIV Research Program (MHRP) Walter Reed Army Institute of Research (WRAIR) July 31, 2014 Clinical Evaluation of PIMA Point-of-Care Assay for Evaluation of CD4 Cell Counts Malia JA 1, Giese RJ 1, Manak M 2, Bryant M 3, Crawford K 2, Lomabardi K 2, Hale B 4 and Peel SA 1 1 Walter Reed Army Institute of Research, MHRP-WRAIR, Silver Spring, MD, 2 Henry Jackson Foundation, MHRP- HJF, Silver Spring, MD, USA; USA; 3 Howard University, Washington, DC, USA, 4 DoD HIV/AIDS Prevention Program, San Diego, CA, USA Malia JA 1, Giese RJ 1, Manak M 2, Bryant M 3, Crawford K 2, Lomabardi K 2, Hale B 4 and Peel SA 1 1 Walter Reed Army Institute of Research, MHRP-WRAIR, Silver Spring, MD, 2 Henry Jackson Foundation, MHRP- HJF, Silver Spring, MD, USA; USA; 3 Howard University, Washington, DC, USA, 4 DoD HIV/AIDS Prevention Program, San Diego, CA, USA

2 MHRP Clinical Evaluation of PIMA Point-of-Care Assay for Evaluation of CD4 Cell Counts  Background  CD4: Key predictive marker of disease progression WHO recommends initiation of therapy when CD4+ drop below 500 cells/  l  Standard: Complex testing, time consuming, highly trained personnel & expensive.  Benefits of POC Fully automated, rapid, minimum training, well suited for testing at remote sites  Materials and Methods  Prospective, random sampling 210 Adults HIV+ across spectrum of CD4 levels  PIMA: Disposable cartridge with sealed reagents Reference lab & clinic by nurse  Evaluation: PIMA Venous and Fingerstick vs. BD FACSCanto II At critical low and mid levels of CD4

3 MHRP RESULTS RESULTS Fig 2. Plot of CD4 counts as obtained by the Gold Standard FACS Canto vs that from PIMA Venous or PIMA Fingerstick. Fig 3. Bland-Altman analysis of Mean vs Difference in CD4 counts between the FACS Canto and PIMA Venous or PIMA Fingerstick.

4 MHRPCONCLUSION  Venous Blood samples; Coefficient of Correlation >85.9%  Fingerstick assay  excellent at low and high CD4+ ranges  less reliable at the critical mid- range.  Minimal space and resources.  Suitable for use in resource limited settings. We would like to acknowledge the Howard University General Clinical Research Center and their dedicated staff for their collaboration and efforts.

5 Thank You


Download ppt "MHRP  The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department of Defense."

Similar presentations


Ads by Google